PMV Pharmaceuticals

PMVP · NASDAQ

$1.39+$0.135 (+10.76%)TodayMarket closed ·
Prev close $1.26

Who owns PMVP

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 51.1% of PMVP’s shares.

  • BML Capital Management LLC10.0%
  • Tang Capital Management, LLC8.0%
  • Sio Capital Management, LLC4.9%
  • Euclidean Capital, L.L.C.4.9%
  • Next 6 largest institutions23.2%
  • All other shareholders48.9%
Top institutional holders of PMVP
HolderShares% of shares
BML Capital Management LLC5.33M9.99%
Tang Capital Management, LLC4.25M7.96%
Sio Capital Management, LLC2.63M4.94%
Euclidean Capital, L.L.C.2.63M4.93%
Adage Capital Management, L.P.2.36M4.43%
Acadian Asset Management LLC2.22M4.16%
Vanguard Capital Management, LLC2.01M3.77%
ArrowMark Colorado Holdings, LLC1.96M3.67%
Two Sigma Investments, LP1.95M3.66%
Eversept Partners, LP1.89M3.55%

Largest mutual fund holders

Top mutual fund holders of PMVP
HolderShares% of shares
Vanguard Total Stock Market Index Fund1.49M2.79%
Meridian Small Cap Growth Fund1.06M1.98%
Vanguard Extended Market Index Fund452.36K0.85%
Bridgeway Ultra-Small Company Fund331.45K0.62%
Fidelity Extended Market Index Fund215.53K0.40%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of PMVP in the last 6 months.

Latest PMVP insider transactions
InsiderTypeSharesValue
Eckler Matthew JosephAward84.00K—
FLOWERS KIRSTENAward42.00K—
Stelzer LaurieAward42.00K—
BAUM CHARLES MAward42.00K—
Gallagher Carol GiltnerGift42.00K—
Gallagher Carol GiltnerGift42.00K—
Gallagher Carol GiltnerAward42.00K—
LEVINE ARNOLD JAward42.00K—

Short interest

Settled Sep 30, 2026

Shares short
2.79M
Days to cover
3.59
% of shares outstanding
5.24%
Average daily volume
778.15K
Change since last report
−4.3%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.